CagriSema is intended for once-weekly subcutaneous treatment
DSIP crosses the blood-brain barrier freely an unusual property for a peptide of its size via a non-competitive, non-saturable passive mechanism whose physicochemical determinants (lipophilicity, charge, molecular weight, and protein-binding) are now well characterised
If you're feeling sluggish, foggy, or just not like yourself, it might be time to check your B12 levels
Once a Victoza or Saxenda pen is used for the first time, it should be discarded after 30 days, regardless of whether medication remains in the pen
A 30ml vial offers the most flexibility for multi-dose use, while 10ml vials are ideal for shorter-run preparations